Pharmadrug Inc.
LMLLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $75 | $411 | $9 | $958 |
| Short-Term Investments | $0 | $12 | $321 | $337 |
| Receivables | $23 | $19 | $997 | $22 |
| Inventory | $0 | $0 | $0 | $156 |
| Other Curr. Assets | $49 | $154 | $14 | $120 |
| Total Curr. Assets | $147 | $596 | $1,340 | $1,594 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $100 |
| Goodwill | $0 | $0 | $6,243 | $10,474 |
| Intangibles | $565 | $603 | $4,530 | $7,353 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $467 | $952 |
| Other NC Assets | $0 | $0 | -$467 | -$952 |
| Total NC Assets | $565 | $603 | $10,772 | $17,927 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $712 | $1,199 | $12,112 | $19,520 |
| Liabilities | – | – | – | – |
| Payables | $370 | $450 | $525 | $249 |
| Short-Term Debt | $1,349 | $1,767 | $1,423 | $43 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $237 | $449 | $249 | $188 |
| Total Curr. Liab. | $1,956 | $2,665 | $2,197 | $480 |
| LT Debt | $0 | $0 | $0 | $824 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $260 | $1,010 | $1,255 |
| Other NC Liab. | $0 | $0 | $70 | $97 |
| Total NC Liab. | $0 | $260 | $1,080 | $2,175 |
| Other Liabilities | $0 | -$260 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $80 |
| Total Liabilities | $1,956 | $2,665 | $3,277 | $2,655 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $33,990 | $33,212 | $31,218 | $30,607 |
| Retained Earnings | -$39,107 | -$38,297 | -$25,118 | -$19,404 |
| AOCI | -$31 | -$46 | -$25 | -$122 |
| Other Equity | $3,746 | $3,426 | $2,761 | $5,784 |
| Total Equity | -$1,403 | -$1,705 | $8,835 | $16,865 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $159 | $239 | $0 | $0 |
| Total Liab. & Tot. Equity | $712 | $1,199 | $12,112 | $19,520 |
| Net Debt | $1,274 | $1,356 | $1,414 | -$92 |